COVID-19 and patients with immune-mediated inflammatory diseases undergoing pharmacological treatments: a rapid living systematic review

COVID-19 and patients with immune-mediated inflammatory diseases undergoing pharmacological treatments: a rapid living systematic review

ABSTRACT BACKGROUND: Patients with immune-mediated inflammatory diseases (IMID) are at increased risk of infection. OBJECTIVE: To assess whether patients undergoing pharmacological treatment for IMID present higher risk of worse outcomes when diagnosed with COVID-19. DESIGN AND SETTING: Rapid sys...

Full description

Bibliographic Details
Main Authors: Aline Pereira da Rocha, Álvaro Nagib Atallah, Ana Carolina Pereira Nunes Pinto, César Ramos Rocha-Filho, Keilla Martins Milby, Vinicius Tassoni Civile, Nelson Carvas Junior, Felipe Sebastião de Assis Reis, Laura Jantsch Ferla, Gabriel Sodré Ramalho, Giulia Fernandes Moça Trevisani, Maria Eduarda dos Santos Puga, Virgínia Fernandes Moça Trevisani
Format: Article
Language:English
Published: Associação Paulista de Medicina 2020-12-01
Series:São Paulo Medical Journal
Subjects:
Immunosuppressive agents
Antirheumatic agents
Coronavirus infections
Systematic review [publication type]
Rheumatic diseases
Immune-mediated inflammatory diseases
Immune-modulating therapies
Evidence-based health
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802020000600515&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802020000600515&tlng=en

Similar Items